Epicondylitis, Lateral Clinical Trial
— DA-SARCOfficial title:
Randomized Clinical Trial Comparing Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis
This study aims to compare arthroscopic resection (surgical intervention) versus infiltration of cytokine rich serum (CRS) (proteins derived from the patient's own blood) for the treatment of lateral epicondylitis (LE).
Status | Recruiting |
Enrollment | 86 |
Est. completion date | December 1, 2023 |
Est. primary completion date | July 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Over 18 years of age - Patients with persistent pain (EVA > 5) at lateral epicondyle level of at least 3 months duration. - Patients with a diagnosis of chronic lateral epicondylitis confirmed with a complementary diagnostic test such as Echo or MRI. - Availability to follow the study protocol for up to 24 months. - Patients with the ability to understand study information and give informed consent. - Patients who sign informed consent. - Normal hematologic parameters. Exclusion Criteria: - Local infection present. - Patients who have been treated with corticosteroid infiltrations in the same area in the past 4 months. - Patients who have received treatment with growth factors, PRP, cytokines, or new drug treatments in the same area in the last 12 months. - Pregnancy or breast-feeding. - Neoplastic disease. - Patients being treated with immunosuppressants (medical evaluation). - Patients undergoing arthroscopic surgery of the same elbow. - Active liver disease. - Immunosuppressive or immunodeficiency states. - Coagulation deficit or abnormalities. - Thrombocytopenia. - Treatment with anticoagulants. - Difficulty understanding and following study procedures. - Participation in a clinical trial with medications. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Clínic i Provincial de Barcelona | Barcelona | |
Spain | Corporació Sanitària Parc Taulí | Sabadell | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Corporacion Parc Tauli | Tecnologia Regenerativa Qrem S.L. |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain assessment | reduction of pain to 6 months measured with the Visual Analogue Scale (EVA) scale. The specification of the efficacy parameter is an absolute improvement of the 2-point scale. | 6 months | |
Secondary | Pain assessment with Visual Analogue Scale (EVA) scale | Visual Analogue Scale (EVA) from 0 to 10 points, being 0 no pain, and 10 maximum pain | 15 days, 1-3-12-24 months after intervention | |
Secondary | Patient-Related Tennis Elbow Evaluation (PRTEE) | The Patient-Rated Tennis Elbow Evaluation questionnaire (PRTEE) is a specific questionnaire available for assessing the health status of patients with lateral epicondylitis. It is a is a 15-item questionnaire allows patients to rate their levels of tennis elbow pain and disability from 0 to 10, and consists in two subscales:
PAIN subscale (0 = no pain, 10 = worst imaginable) - 5 items FUNCTION subscale (0 = no difficulty, 10 = unable to do) Specific activities - 6 items Usual activities - 4 items |
15 days, 1-3-6-12-24 months after intervention | |
Secondary | Grip force | measured with a palm grip dynamometer, in kilos | 15 days, 1-3-6-12-24 months after intervention | |
Secondary | occurrence of pain with resisted wrist extension | assessed during medical examination | 15 days, 1-3-6-12-24 months after intervention | |
Secondary | Number of participants with complications related to the treatment | assessed during medical examination | 15 days, 1-3-6-12-24 months after intervention | |
Secondary | Revision of anti-inflammatory medication and its dose | assessed during medical examination | 15 days, 1-3-6-12-24 months after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05238090 -
Efficacy of a Stretching Protocol for Lateral Epicondylitis
|
N/A | |
Recruiting |
NCT06442618 -
Effectiveness of Extracorporeal Shockwave Therapy and Nutraceutical Supplementation in the Treatment of Epicondylitis: a Clinical Trial
|
N/A | |
Completed |
NCT04026191 -
OVT for Epicondylosis (Tennis Elbow)
|
N/A | |
Completed |
NCT04875338 -
Injection in the Treatment of Lateral Epicondylitis. Randomized Controlled Trial
|
Phase 3 | |
Completed |
NCT06160011 -
Epicondylar Muscle Activation in Tennis Players
|
N/A |